SEC Form 4 · accession 0001415889-16-004938
Echo Therapeutics, Inc. · ECTE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shepard M Goldberg
Director
Period of report
Mar 1, 2016
Accepted (ET)
Mar 3, 2016 · 2:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001031927
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options (Right to Buy)F2,F1 | $1.12 | Mar 1, 2016 | A | 150,000 | A | — | Mar 1, 2026 | Common Stock | 150,000 | 37,500 | D |
Explanation of responses
- F125% of the options vest immediately and 25% vest on each of July 1, 2016, October 1, 2016 and January 1, 2017.
- F2Granted pursuant to the Echo Therapeutics, Inc. 2008 Equity Compensation Plan.